Frontline therapy and the role of high-dose consolidation in mantle cell lymphoma
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.
BCL2 inhibition and CLL: the role of venetoclax
The importance of the microenvironment in multiple myeloma
The success story of indolent disease treatment expanded to difficult-to-treat patient groups